For full therapeutic benefit regular usage is essential. The co-operation of the patient should be sought to comply with the regular dosage schedule and it should be explained that maximum relief may not be obtained within the first few applications. Systemic effects of nasal corticosteroids may occur particularly when used at high doses for prolonged periods. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch. Benzalkonium chloride may cause irritation or swelling inside the nose, especially if used for a long period of time.

How and when to use beclometasone nasal spray - NHS

Rarely, using corticosteroid medications for a long time can make it more difficult for your body to respond to physical stress. Before having surgery or emergency treatment, or if you get a serious illness/injury, tell your doctor or dentist that you are using this medication or have used this medication within the past few months. Beclometasone nasal spray is also available from pharmacies and on prescription without a brand name, ie as the generic medicine. Beconase hayfever nasal sprays contain the active ingredient beclometasone dipropionate, 50 micrograms per spray. Beclometasone is a type of medicine known as a corticosteroid (or steroid).

If you forget to use it

Beclometasone nasal (nose) spray is used to treat cold-like symptoms caused by allergic rhinitis. This is swelling (inflammation) of the inside of your nose that can be brought on by allergies like hay fever.

BECONASE FAQ | Beconase BECONASE FAQ | Beconase

If you're using a new bottle, it may not work first time. Pump the spray a few times until a fine mist comes out. You'll also need to do this if you have not used the bottle for a few days. Follow the instructions provided with the nasal spray. Shake the bottle gently before each use. Take care to avoid getting the spray in your eyes. Follow the instructions that come with your medicine. Do not use more than 4 sprays per nostril in 24 hours. Changes to your dose Bend your head forward slightly and carefully put the nozzle into your other nostril keeping the bottle upright.The recommended dosage is two sprays into each nostril twice daily (400 micrograms/day). Once control has been established it may be possible to maintain control with fewer sprays. A dosage regimen of one spray into each nostril morning and evening has been shown to be efficacious in some patients. However, should symptoms recur, patients should revert to the recommended dosage of two sprays into each nostril morning and evening. The minimum dose should be used at which effective control of symptoms is maintained. Total daily administration should not normally exceed eight sprays. The nasal spray won't relieve the symptoms of nasal inflammation straight away, and it can take a few days to build up its effect. How do I use Beconase hayfever nasal spray? If you forget doses often, it may help to set an alarm to remind you. You could also ask your pharmacist for advice on other ways to help you remember to take your medicine. If you use too much

BECONASE AQ - GSKpro PRESCRIBING INFORMATION BECONASE AQ - GSKpro

If your symptoms haven't improved after seven days of using Beconase hayfever ask your pharmacist or doctor for advice. Do not exceed the recommended dose. Corticosteroids are hormones that are produced naturally by the adrenal glands and have many important functions, including control of inflammatory responses. Beclometasone is a synthetic corticosteroid and is used as a nasal spray to reduce inflammation in the nasal passages (rhinitis). Del Cuvillo A, Mullol J, Bartra J, Dvila I, Juregui I, Montoro J, Sastre J, Valeron AL. Comparative pharmacology of the H1 antihistamines. J Invest Alergol Clin Immunol 2006;16(S1):3-12. If you have beclometasone nasal spray on prescription, your doctor will tell you how often to use the nasal spray and when to change your dose. How to use itBeconase Hayfever 180 sprayis a highly effective, non-drowsy medication for treating and preventing airborne allergies such as hayfever, dust and pet allergy any time during the year. Following oral administration of BDP in healthy males, the systemic absorption was also assessed by measuring the plasma concentrations of its active metabolite B-17-MP, for which the absolute bioavailability following oral administration is 41% (95% CI 27%, 62%). There is inadequate evidence of safety in human pregnancy. Administration of corticosteroids to pregnant animals can cause abnormalities of foetal development including cleft palate and intra-uterine growth retardation. There may therefore be a very small risk of such effects in the human foetus. It should be noted, however, that the foetal changes in animals occur after relatively high systemic exposure. Beconase Aqueous Nasal Spray delivers beclometasone dipropionate directly to the nasal mucosa and so minimises systemic exposure.

About beclometasone nasal spray - NHS

Schran HF, Petryk L, Chang CT, O’Connor R, Gelbert MB. The pharmacokinetics and bioavailability of clemastine and phenylpropanolamine in single-component and combination formulations. J Clin Pharmacol 1996;36:911-922.

Check store stock

This is particularly important if you are or have recently been using any other medicines that contain corticosteroids, for example tablets, injections, eye or nose drops, creams, asthma inhalers, or other similar nasal sprays. You may be more likely to get side effects if you're using more than one type of steroid medication and your doctor may want to monitor you more closely. Beclometasone is not known to affect other medicines when administered into the nose as a nasal spray. It's fine to use Beconase hayfever nasal spray with other types of hay fever treatment, such as antihistamines or eye drops. As beclometasone reduces inflammation it's also found in various medicines used to treat inflammatory conditions in other parts of the body. These include beclometasone inhalers for asthma, beclometasone creams and ointments for eczema, and Clipper tablets for inflammatory bowel disease. Simons FE, Simons KJ. Clinical pharmacology of new histamine H1 receptor antagonists. Clin Pharmacokinet 1999;36(5):329-52.